Articoli con mandati relativi all'accesso pubblico - Andrea CuconatiUlteriori informazioni
Non disponibile pubblicamente: 1
Design and synthesis of N-alkyldeoxynojirimycin derivatives with improved metabolic stability as inhibitors of BVDV and Tacaribe virus
Y Du, H Ye, F Guo, L Wang, T Gill, N Khan, A Cuconati, JT Guo, TM Block, ...
Bioorganic & medicinal chemistry letters 23 (14), 4258-4262, 2013
Mandati: US National Institutes of Health
Disponibili pubblicamente: 22
Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation
D Cai, C Mills, W Yu, R Yan, CE Aldrich, JR Saputelli, WS Mason, X Xu, ...
Antimicrobial agents and chemotherapy 56 (8), 4277-4288, 2012
Mandati: US National Institutes of Health
Inhibition of hepatitis B virus replication by the host zinc finger antiviral protein
R Mao, H Nie, D Cai, J Zhang, H Liu, R Yan, A Cuconati, TM Block, ...
PLoS pathogens 9 (7), e1003494, 2013
Mandati: US National Institutes of Health
Interferon induction of IFITM proteins promotes infection by human coronavirus OC43
X Zhao, F Guo, F Liu, A Cuconati, J Chang, TM Block, JT Guo
Proceedings of the National Academy of Sciences 111 (18), 6756-6761, 2014
Mandati: US National Institutes of Health
Sulfamoylbenzamide derivatives inhibit the assembly of hepatitis B virus nucleocapsids
MR Campagna, F Liu, R Mao, C Mills, D Cai, F Guo, X Zhao, H Ye, ...
Journal of virology 87 (12), 6931-6942, 2013
Mandati: US National Institutes of Health
Design, synthesis, and biological evaluation of triazolo-pyrimidine derivatives as novel inhibitors of hepatitis B virus surface antigen (HBsAg) secretion
W Yu, C Goddard, E Clearfield, C Mills, T Xiao, H Guo, JD Morrey, ...
Journal of medicinal chemistry 54 (16), 5660-5670, 2011
Mandati: US National Institutes of Health
Chronic hepatitis B: what should be the goal for new therapies?
TM Block, R Gish, H Guo, A Mehta, A Cuconati, WT London, JT Guo
Antiviral research 98 (1), 27-34, 2013
Mandati: US National Institutes of Health
Activation of pattern recognition receptor-mediated innate immunity inhibits the replication of hepatitis B virus in human hepatocyte-derived cells
H Guo, D Jiang, D Ma, J Chang, AM Dougherty, A Cuconati, TM Block, ...
Journal of virology 83 (2), 847-858, 2009
Mandati: US National Institutes of Health
Indoleamine 2, 3-dioxygenase mediates the antiviral effect of gamma interferon against hepatitis B virus in human hepatocyte-derived cells
R Mao, J Zhang, D Jiang, D Cai, JM Levy, A Cuconati, TM Block, JT Guo, ...
Journal of virology 85 (2), 1048-1057, 2011
Mandati: US National Institutes of Health
HBV core protein allosteric modulators differentially alter cccDNA biosynthesis from de novo infection and intracellular amplification pathways
F Guo, Q Zhao, M Sheraz, J Cheng, Y Qi, Q Su, A Cuconati, L Wei, Y Du, ...
PLoS pathogens 13 (9), e1006658, 2017
Mandati: US National Institutes of Health
Small molecule inhibitors of ER α-glucosidases are active against multiple hemorrhagic fever viruses
J Chang, TK Warren, X Zhao, T Gill, F Guo, L Wang, MA Comunale, Y Du, ...
Antiviral research 98 (3), 432-440, 2013
Mandati: US National Institutes of Health
Spinoculation enhances HBV infection in NTCP-reconstituted hepatocytes
R Yan, Y Zhang, D Cai, Y Liu, A Cuconati, H Guo
PloS one 10 (6), e0129889, 2015
Mandati: US National Institutes of Health
Inhibition of endoplasmic reticulum-resident glucosidases impairs severe acute respiratory syndrome coronavirus and human coronavirus NL63 spike protein-mediated entry by …
X Zhao, F Guo, MA Comunale, A Mehta, M Sehgal, P Jain, A Cuconati, ...
Antimicrobial agents and chemotherapy 59 (1), 206-216, 2015
Mandati: US National Institutes of Health
Alkylated porphyrins have broad antiviral activity against hepadnaviruses, flaviviruses, filoviruses, and arenaviruses
H Guo, X Pan, R Mao, X Zhang, L Wang, X Lu, J Chang, JT Guo, S Passic, ...
Antimicrobial agents and chemotherapy 55 (2), 478-486, 2011
Mandati: US National Institutes of Health
Establishment of an inducible HBV stable cell line that expresses cccDNA-dependent epitope-tagged HBeAg for screening of cccDNA modulators
D Cai, X Wang, R Yan, R Mao, Y Liu, C Ji, A Cuconati, H Guo
Antiviral research 132, 26-37, 2016
Mandati: US National Institutes of Health
Design, Synthesis, and Biological Evaluation of N-Alkylated Deoxynojirimycin (DNJ) Derivatives for the Treatment of Dengue Virus Infection
W Yu, T Gill, L Wang, Y Du, H Ye, X Qu, JT Guo, A Cuconati, K Zhao, ...
Journal of medicinal chemistry 55 (13), 6061-6075, 2012
Mandati: US National Institutes of Health
Preclinical profile of AB-423, an inhibitor of hepatitis B virus pregenomic RNA encapsidation
N Mani, AG Cole, JR Phelps, A Ardzinski, KD Cobarrubias, A Cuconati, ...
Antimicrobial agents and chemotherapy 62 (6), 10.1128/aac. 00082-18, 2018
Mandati: US National Institutes of Health
A novel benzodiazepine compound inhibits yellow fever virus infection by specifically targeting NS4B protein
F Guo, S Wu, J Julander, J Ma, X Zhang, J Kulp, A Cuconati, TM Block, ...
Journal of virology 90 (23), 10774-10788, 2016
Mandati: US National Institutes of Health
RO 90-7501 enhances TLR3 and RLR agonist induced antiviral response
F Guo, J Mead, N Aliya, L Wang, A Cuconati, L Wei, K Li, TM Block, ...
Public Library of Science 7 (10), e42583, 2012
Mandati: US National Institutes of Health
Screening and identification of compounds with antiviral activity against hepatitis B virus using a safe compound library and novel real-time immune-absorbance PCR-based high …
J Lamontagne, C Mills, R Mao, C Goddard, D Cai, H Guo, A Cuconati, ...
Antiviral research 98 (1), 19-26, 2013
Mandati: US National Institutes of Health
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software